{
    "doi": "https://doi.org/10.1182/blood.V106.11.5381.5381",
    "article_title": "Benefit of Early Switch to Liposomal Amphotericin B in Patients with Amphotericin B Deoxycholate-Induced Nephrotoxicity Versus Late Switch. ",
    "article_date": "November 16, 2005",
    "session_type": "Abstracts Not Selected for Presentation",
    "abstract_text": "Amphotericin B deoxycholate (AmBd) nephrotoxicity increases morbidity and mortality however there are no clear guidelines when to switch to liposomal amphotericin B (LAB). We evaluated the benefit of Early Switch (ES) to LAB in patients with AmBd compared to Late Switch (LS). In this prospective randomized multicenter trial, standard AmBd 1mg/kg/d is initiated in neutropenic patients with haematological malignancies as empirical antifungal therapy (V0). If serum creatinine (SCr) increased of 30% from baseline V0, they were randomized (V1) to LAB 3mg/kg/d (ES) or to pursue AmBd (no switch). In a second step, AmBd treated patients were switched to LAB (LS) if their serum creatinine doubled from V0 or reached a value \u2265 170 \u03bcmol/l up to the end of treatment (V2). The analysis included 29 patients [ES=14; no switch=15 with late switch for 9 of them]. Demographics and mean duration of AmBd treatment prior randomization were similar in both groups. Early switch allowed a statistically significant (p=0.04) decrease in serum creatinine (\u22123.1%) from V1 to V2 as compared with a mean increase of +16.2% in the LS + no switch groups and also demonstrated a significant (p=0.04) increase (+5.1%) in creatinine clearance (ml/min) compared to a decrease (\u221210.3%) in the LS + no switch groups. This randomised trial demonstrated that an early switch to LAB improves and preserves renal function compared with late switch. Significant reduction of drug-induced nephrotoxicity may impact positively clinical outcomes and provide patients with greater options for chemotherapy treatments. Evolution of renal function  Criteria (mean) . ES . LS + no switch . p . SCr at V0 (\u03bcmol/l) 67.2 67.3 NS SCr at V1 (\u03bcmol/l) 109.0 108.2 NS SCr at V2 (\u03bcmol/l) 104.5 123.1 0.08 Evolution of SCr V1 - V2 (%) \u2212 3.1 + 16.2 0.04 Evolution of ClCr V1 - V2 (%) + 5.1 \u2212 10.3 0.04 Criteria (mean) . ES . LS + no switch . p . SCr at V0 (\u03bcmol/l) 67.2 67.3 NS SCr at V1 (\u03bcmol/l) 109.0 108.2 NS SCr at V2 (\u03bcmol/l) 104.5 123.1 0.08 Evolution of SCr V1 - V2 (%) \u2212 3.1 + 16.2 0.04 Evolution of ClCr V1 - V2 (%) + 5.1 \u2212 10.3 0.04 View Large",
    "topics": [
        "amphotericin b",
        "amphotericin b liposomal",
        "deoxycholate",
        "nephrotoxicity",
        "creatinine tests, serum",
        "amphotericin b, deoxycholate drug combination",
        "antifungal agents",
        "chemotherapy regimen",
        "creatinine clearance",
        "hematologic neoplasms"
    ],
    "author_names": [
        "Franc\u0327oise Isnard",
        "Jean P. Laporte",
        "Patrice Chevallier",
        "Arnaud Pigneux",
        "Patrick Tilleul",
        "Antoine Lafuma",
        "Lamine Mahi",
        "Gilbert Deray"
    ],
    "author_dict_list": [
        {
            "author_name": "Franc\u0327oise Isnard",
            "author_affiliations": [
                " ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Po\u0302le Cance\u0301rologie, Clinique d\u2019He\u0301matologie, Nantes, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Haut Le\u0301ve\u0302que, Pessac, France; ",
                " Pharmacie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " CEMKA-EVAL, Bourg la Reine, France; ",
                " Gilead Sciences, Paris, France and ",
                " Service de Ne\u0301phrologie, Paris Cedex 13, France."
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Jean P. Laporte",
            "author_affiliations": [
                " ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Po\u0302le Cance\u0301rologie, Clinique d\u2019He\u0301matologie, Nantes, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Haut Le\u0301ve\u0302que, Pessac, France; ",
                " Pharmacie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " CEMKA-EVAL, Bourg la Reine, France; ",
                " Gilead Sciences, Paris, France and ",
                " Service de Ne\u0301phrologie, Paris Cedex 13, France."
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Patrice Chevallier",
            "author_affiliations": [
                " ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Po\u0302le Cance\u0301rologie, Clinique d\u2019He\u0301matologie, Nantes, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Haut Le\u0301ve\u0302que, Pessac, France; ",
                " Pharmacie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " CEMKA-EVAL, Bourg la Reine, France; ",
                " Gilead Sciences, Paris, France and ",
                " Service de Ne\u0301phrologie, Paris Cedex 13, France."
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Arnaud Pigneux",
            "author_affiliations": [
                " ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Po\u0302le Cance\u0301rologie, Clinique d\u2019He\u0301matologie, Nantes, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Haut Le\u0301ve\u0302que, Pessac, France; ",
                " Pharmacie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " CEMKA-EVAL, Bourg la Reine, France; ",
                " Gilead Sciences, Paris, France and ",
                " Service de Ne\u0301phrologie, Paris Cedex 13, France."
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Patrick Tilleul",
            "author_affiliations": [
                " ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Po\u0302le Cance\u0301rologie, Clinique d\u2019He\u0301matologie, Nantes, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Haut Le\u0301ve\u0302que, Pessac, France; ",
                " Pharmacie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " CEMKA-EVAL, Bourg la Reine, France; ",
                " Gilead Sciences, Paris, France and ",
                " Service de Ne\u0301phrologie, Paris Cedex 13, France."
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antoine Lafuma",
            "author_affiliations": [
                " ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Po\u0302le Cance\u0301rologie, Clinique d\u2019He\u0301matologie, Nantes, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Haut Le\u0301ve\u0302que, Pessac, France; ",
                " Pharmacie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " CEMKA-EVAL, Bourg la Reine, France; ",
                " Gilead Sciences, Paris, France and ",
                " Service de Ne\u0301phrologie, Paris Cedex 13, France."
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Lamine Mahi",
            "author_affiliations": [
                " ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Po\u0302le Cance\u0301rologie, Clinique d\u2019He\u0301matologie, Nantes, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Haut Le\u0301ve\u0302que, Pessac, France; ",
                " Pharmacie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " CEMKA-EVAL, Bourg la Reine, France; ",
                " Gilead Sciences, Paris, France and ",
                " Service de Ne\u0301phrologie, Paris Cedex 13, France."
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gilbert Deray",
            "author_affiliations": [
                " ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " Po\u0302le Cance\u0301rologie, Clinique d\u2019He\u0301matologie, Nantes, France; ",
                " Service d\u2019He\u0301matologie, Ho\u0302pital Haut Le\u0301ve\u0302que, Pessac, France; ",
                " Pharmacie, Ho\u0302pital Saint Antoine, Paris, France; ",
                " CEMKA-EVAL, Bourg la Reine, France; ",
                " Gilead Sciences, Paris, France and ",
                " Service de Ne\u0301phrologie, Paris Cedex 13, France."
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-04-26T13:03:13",
    "is_scraped": "1"
}